OBO_ID (LABEL):	CHEBI_28934 (vitamin D2)

IGNORANCE CATEGORY:	anomaly_curious_finding

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
PMC4600246	10/2015	S69-PMC4600246	['the mechanisms responsible include (1) activation of growth-inhibiting proteins requiring Vitamin K2, such as prothrombin,62(2) Arylation pathways,63(3) activation of growth arrest Genes such as gas 6,64and (4) and increased C-Jun and C-Myc mrna Expression in Hepatoma Cells.57\npreventing the Recurrence of hcc is an IMPORTANT STRATEGY, ESPECIALLY CONSIDERING the fact that EVEN after patients undergo curative therapy recurrence rates REMAIN high.65while triple combination therapy with Boceprevir or Telaprevir, pegylated interferon (ifn) and Ribavirin is effective for the treatment of hepatitis c virus (Hcv), INFORMATION on preventing hcc development and/or recurrence as well as all-cause mortality is LACKING.6667moreover, this combination therapy is expensive, REQUIRES injections (ifn) and is OFTEN not well tolerated DUE TO adverse events (ie, fever and pancytopenia).']	[('IMPORTANT_CONSIDERATION', 317), ('FUTURE_WORK', 327), ('IMPORTANT_CONSIDERATION', 337), ('IMPORTANT_CONSIDERATION', 348), ('ANOMALY_CURIOUS_FINDING', 374), ('INCOMPLETE_EVIDENCE', 436), ('INCOMPLETE_EVIDENCE', 614), ('FULL_UNKNOWN', 708), ('INCOMPLETE_EVIDENCE', 708), ('IMPORTANT_CONSIDERATION', 769), ('PROBABLE_UNDERSTANDING', 802), ('PROBLEM_COMPLICATION', 827)]	12	[('CHEBI_28934', 'vitamin D2', 90, 'vitamin K2'), ('PR_000017299', 'VIP peptides', 90, 'vitamin K2'), ('GO_0006915', 'apoptotic process', 128, 'arylation'), ('SO_0000704', 'gene', 181, 'genes'), ('PR_000004968', 'calretinin', 225, 'c-Jun'), ('PR_000000084', 'c-myc protein', 235, 'c-Myc'), ('GO_0010467', 'gene expression', 246, 'expression'), ('CL_0000632', 'hepatic stellate cell', 260, 'hepatoma cells'), ('GO_0000003', 'reproduction', 293, 'recurrence'), ('CHEBI_68621', 'boceprevir', 488, 'boceprevir'), ('CHEBI_68593', 'eurysterol B(1-)', 502, 'telaprevir'), ('CHEBI_63580', 'ribavirin', 545, 'ribavirin'), ('NCBITaxon_10088', 'Mus <genus>', 608, 'HCV')]
PMC4600246	10/2015	S4-PMC4600246	['introduction\nVitamin K is a fat-soluble Vitamin, IMPORTANT for the function of numerous proteins within the body, such as the Coagulation factors (ii, vii, Ix, x and protein c and protein s), Osteocalcin (a bone-Forming Protein) and Matrix-Gla Protein (Mgp) (an anticalcification protein), to name a few.1–3vitamin K exists naturally as Vitamin K1(Phylloquinone) and Vitamin K2(Menaquinone, mk-4 through mk-10).2–5vitamin K1Is mainly found in green leafy vegetables as well as olive oil and soyabean oil, whereas Vitamin K2(Menaquinone) is found in small amounts in Chicken, butter, Egg Yolks, cheese and fermented soyabeans (BETTER KNOWN as natto).26–9\nVitamin K1And Vitamin K2Are REQUIRED for the γ-glutamyl carboxylation of all Vitamin K-dependent proteins.2DESPITE the fact that Mammalian bacterial Intestinal flora are able to produce Vitamin K2, the amount produced IS THOUGHT TO be negligible.2the adequate intake (ai) for Vitamin K HAS BEEN PROPOSED to be 90\u2005µg/day for women and 120\u2005µg/day for men.210HOWEVER, it HAS BEEN SPECULATED that the ai for Vitamin K (90–120\u2005µg/day) is not sufficient to induce complete carboxylation of all Vitamin K-dependent proteins.21112\n\nvitamin K deficiency\nthe measurement and treatment of Vitamin K deficiency based on Blood tests is not perfect.']	[('IMPORTANT_CONSIDERATION', 49), ('INCOMPLETE_EVIDENCE', 626), ('IMPORTANT_CONSIDERATION', 682), ('ANOMALY_CURIOUS_FINDING', 760), ('INCOMPLETE_EVIDENCE', 872), ('INCOMPLETE_EVIDENCE', 875), ('INCOMPLETE_EVIDENCE', 940), ('INCOMPLETE_EVIDENCE', 949), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1007), ('INCOMPLETE_EVIDENCE', 1022), ('INCOMPLETE_EVIDENCE', 1031)]	11	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin K'), ('CHEBI_33229', 'vitamin (role)', 40, 'vitamin'), ('GO_0050817', 'coagulation', 126, 'coagulation'), ('PR_000008875', 'islet amyloid polypeptide', 156, 'IX'), ('PR_000011634', 'oxidized low-density lipoprotein receptor 1', 192, 'osteocalcin'), ('PR_000004759', 'Bloom syndrome protein', 211, '-forming protein'), ('GO_0031012', 'extracellular matrix', 233, 'matrix'), ('PR_000010430', 'MAP kinase-interacting serine/threonine-protein kinase 2', 233, 'matrix-Gla protein'), ('PR_000010430', 'MAP kinase-interacting serine/threonine-protein kinase 2', 253, 'MGP'), ('CHEBI_52071', 'dextran', 315, 'K'), ('CHEBI_33229', 'vitamin (role)', 337, 'vitamin'), ('PR_000004483', 'V-type proton ATPase subunit C 1', 337, 'vitamin K1'), ('CHEBI_26124', 'phytosteroid', 348, 'phylloquinone'), ('CHEBI_28934', 'vitamin D2', 367, 'vitamin K2'), ('PR_000017299', 'VIP peptides', 367, 'vitamin K2'), ('CHEBI_18154', 'polysaccharide', 378, 'menaquinone'), ('PR_000009255', 'potassium voltage-gated channel subfamily E member 1', 422, 'K1is'), ('CHEBI_28934', 'vitamin D2', 513, 'vitamin K2'), ('PR_000017299', 'VIP peptides', 513, 'vitamin K2'), ('CHEBI_18154', 'polysaccharide', 524, 'menaquinone'), ('NCBITaxon_33208', 'Metazoa', 566, 'chicken'), ('UBERON_0005079', 'eggshell', 583, 'egg yolks'), ('CHEBI_33229', 'vitamin (role)', 654, 'Vitamin'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 654, 'Vitamin K1and'), ('PR_000017209', 'utrophin', 668, 'vitamin K2are'), ('CHEBI_27300', 'vitamin D', 731, 'vitamin K'), ('NCBITaxon_40674', 'Mammalia', 783, 'mammalian'), ('UBERON_0000160', 'intestine', 803, 'intestinal'), ('CHEBI_28934', 'vitamin D2', 840, 'vitamin K2'), ('PR_000017299', 'VIP peptides', 840, 'vitamin K2'), ('CHEBI_27300', 'vitamin D', 930, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 1058, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 1142, 'vitamin K'), ('CHEBI_52071', 'dextran', 1186, 'K'), ('CHEBI_27300', 'vitamin D', 1232, 'vitamin K'), ('UBERON_0000178', 'blood', 1262, 'blood')]
PMC4600246	10/2015	S77-PMC4600246	['finally, in the RECENT vitamin k italian (viki) dialysis STUDY, 23.5% of patients were FOUND to be Vitamin K deficient, and this deficiency was FOUND TO BE the strongest PREDICTOR of vertebral fractures (or: 2.94; 95% ci 1.38 to 6.26).72other data HAVE SHOWN that vitamin K2May improve Bone Remodelling in patients with haemodialysis with low Serum Parathyroid hormone levels.73supplementing with at LEAST 200\u2005µg Menaquinone-7 (a form of Vitamin K2) daily MAY help to achieve near maximal protection from vascular calcification, osteoporosis and cancer (measured by maximal gamma carboxylation of Vitamin K dependent proteins).35\n\nconclusion\nVitamin K has a plethora of POTENTIAL IMPLICATIONS, including prevention and treatment of Arterial calcifications, Coronary Heart disease and cancer, improvements in bone strength and reduced risks of fractures as well as improvements in Insulin sensitivity.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 87), ('ANOMALY_CURIOUS_FINDING', 144), ('SUPERFICIAL_RELATIONSHIP', 170), ('INCOMPLETE_EVIDENCE', 248), ('PROBABLE_UNDERSTANDING', 400), ('INCOMPLETE_EVIDENCE', 456), ('INCOMPLETE_EVIDENCE', 670), ('IMPORTANT_CONSIDERATION', 680)]	10	[('CHEBI_27300', 'vitamin D', 99, 'vitamin K'), ('PR_000009481', 'keratin, type II cytoskeletal 5', 272, 'K2may'), ('GO_0046849', 'bone remodeling', 286, 'bone remodelling'), ('UBERON_0001977', 'blood serum', 343, 'serum'), ('UBERON_0001132', 'parathyroid gland', 349, 'parathyroid'), ('CHEBI_18154', 'polysaccharide', 413, 'menaquinone'), ('CHEBI_28934', 'vitamin D2', 438, 'vitamin K2'), ('PR_000017299', 'VIP peptides', 438, 'vitamin K2'), ('CHEBI_27300', 'vitamin D', 597, 'vitamin K'), ('CHEBI_28384', 'vitamin K', 642, 'Vitamin K'), ('UBERON_0001637', 'artery', 732, 'arterial'), ('UBERON_0004151', 'cardiac chamber', 757, 'coronary heart'), ('PR_000045358', 'insulin family protein', 880, 'insulin')]
PMC5273824	1/2017	S102-PMC5273824	['it is NOTED that the DETECTION rate of Serum 25-Oh Vitamin D2 in the study is 19.4%, higher THAN THE USUAL 5% in the general population [3].']	[('ANOMALY_CURIOUS_FINDING', 6), ('INCOMPLETE_EVIDENCE', 21), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92)]	3	[('UBERON_0001977', 'blood serum', 39, 'serum'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 45, '25-OH'), ('CHEBI_28934', 'vitamin D2', 51, 'Vitamin D2'), ('PR_000017279', 'testis-specific basic protein Y 1', 51, 'Vitamin D2')]
